Our Company
Omne Possibile brings together the key disciplines of XNA development: chemical synthesis, genetics,
directed evolution of enzymes and genomes, automated design of molecules and bioproduction pathways.
Omne Possibile has launched two R&D innovation labs in Leuven, Belgium, and Basel, Switzerland,
to accelerate product development and commercialization with a world-class team.
BASEL, SWITZERLAND
- Design & construction of metabolic pathways
- Synthetic genomes & replicons
- Enzymatic, microbial & cellular fluidics
LEUVEN, BELGIUM
- Nucleoside, nucleotide & nucleic acids chemistry
- XNA design & synthesis
- XNA enzymology & amplification
Founders

Philippe Marlière
Head of Genetics

Piet Herdewijn
Head of Chemistry

Sven Panke
ETH Zürich

Patrice Garnier
Entrepreneur

Alexandre Mourandian
Eurekare, Luxembourg
Advisors

Gerard Le Fur
Former CEO of Sanofi-Aventis

Steven Benner
FfAME, Florida

John Chaput
University of California, Irvine

Ada Yonath
Weizmann Institute, Rehovot Nobel Laureate, Chemistry, 2009

Janine Cossy
ESPCI, Paris

Jason Chin
MRC Cambridge

Serge Ratton
Former CSO of Rhodia

Jean-Marie Lehn
University of Strasbourg
Nobel Laureate, Chemistry, 1987